Private equity firm to buy inVentiv Health for $1.1B
The deal is expected to close by this year's third quarter, the firms said in a statement.
InVentiv offers clinical, sales, marketing and communications services. It has clients in the pharmaceutical, life sciences, and healthcare sectors.
An InVentiv representative could not be immediately reached for comment. A spokesperson for Thomas H. Lee Partners declined comment.